The Genital Herpes Treatment market is expected to grow at a CAGR of 7% during the projected period. The genital herpes treatment includes the use of drug types like Acyclovir that can treat herpes virus infections, including shingles. This medication does not cure herpes, but may prevent herpes sores or blisters. Chances of genital herpes are more in the male same-sex partnership compared to female same-sex partnership. Homosexual men are known to be at high risk for herpes simplex virus (HSV), which can be transmitted by direct intimate contact with a person who is shedding virus, and not only through ano-genital sex.
Due to increasing awareness about genital herps treatment and rapidly developing hospital network, are the factors impacting the fastest growth in Asia Pacific region among other region. And North America region holding the major market share of genital herpes treatment market during the forecast period.
Global Genital Herpes Treatment market is segregated on the basis of route of administration as oral, topical and injectable. Based on indication, the global Genital Herpes Treatment market is segmented as HSV-1 and HSV-2. The report also bifurcates global Genital Herpes Treatment market based on distribution channel in hospital pharmacies, retail pharmacies, online pharmacies and drug stores.
Global Genital Herpes Treatment market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The Genital Herpes Treatment market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Abbott Laboratories, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline plc. Are among the major players in the global Genital Herpes Treatment market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Genital Herpes Treatment Market has been segmented as below:
Genital Herpes Treatment Market, by Route of Administration
Genital Herpes Treatment Market, by Indication
Genital Herpes Treatment Market, by Distribution Channel
Genital Herpes Treatment Market, By Region
The report covers:
Report scope:
Global Genital Herpes Treatment market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Genital Herpes Treatment market share. Major industry players with significant revenue share include GlaxoSmithKline plc, Novartis AG, Abbott Laboratories, Sun Pharmaceuticals Industries Ltd., etc.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Hepatitis B Diagnostic Tests Market
Medication Management System Market
Neonatal Thermoregulation Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Advanced technological developments
4.2.2. Increasing awareness about STD
4.3. Restraints
4.3.1. High cost of the products
5. Genital Herpes Treatment Market, By Route of Administration
5.1. Key Points
5.2. Oral
5.3. Injectable
5.4. Topical
6. Genital Herpes Treatment Market, By Indication
6.1. Key Points
6.2. HSV-1
6.3. HSV-2
7. Genital Herpes Treatment Market, By Distribution Channel
7.1. Key Points
7.2. Hospital Pharmacies
7.3. Retail Pharmacies
7.4. Online Pharmacies
7.5. Drug Stores
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers &Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profile
9.1. GlaxoSmithKline plc.
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. Abbott Laboratories
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. Novartis AG
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. Sun Pharmaceuticals Industries Ltd.
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. Mylan N.V.
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
The Genital Herpes Treatment Market has been segmented as below:
Genital Herpes Treatment Market, by Route of Administration
Genital Herpes Treatment Market, by Indication
Genital Herpes Treatment Market, by Distribution Channel
Genital Herpes Treatment Market, By Region
